125 related articles for article (PubMed ID: 23411953)
21. The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease.
Papanikolopoulou A; Landt O; Ntoumas K; Bolomitis S; Tyritzis SI; Constantinides C; Drakoulis N
Clin Chem Lab Med; 2011 Nov; 50(2):379-85. PubMed ID: 22070222
[TBL] [Abstract][Full Text] [Related]
22. The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population.
Wokołorczyk D; Gliniewicz B; Stojewski M; Sikorski A; Złowocka E; Debniak T; Jakubowska A; Górski B; van de Wetering T; Narod SA; Lubiński J; Cybulski C
Eur J Cancer Prev; 2010 Mar; 19(2):167-71. PubMed ID: 19952762
[TBL] [Abstract][Full Text] [Related]
23. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.
Chang BL; Zheng SL; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2002 Mar; 62(6):1784-9. PubMed ID: 11912155
[TBL] [Abstract][Full Text] [Related]
24. Hereditary link: scientists seek clues in genetic risks for prostate cancer.
Printz C
Cancer; 2014 Dec; 120(24):3847-8. PubMed ID: 25474225
[No Abstract] [Full Text] [Related]
25. Clinical uncertainty of prostate cancer genetic risk panels.
Pomerantz M; Freedman ML
Sci Transl Med; 2013 Apr; 5(182):182ed6. PubMed ID: 23616119
[No Abstract] [Full Text] [Related]
26. Germline genetic variants associated with prostate cancer and potential relevance to clinical practice.
Goh CL; Eeles RA
Recent Results Cancer Res; 2014; 202():9-26. PubMed ID: 24531773
[TBL] [Abstract][Full Text] [Related]
27. When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.
Li-Wan-Po A; Farndon P; Cooley C; Lithgow J
Public Health Genomics; 2010; 13(1):55-62. PubMed ID: 19439915
[TBL] [Abstract][Full Text] [Related]
28. Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.
Breyer JP; McReynolds KM; Yaspan BL; Bradley KM; Dupont WD; Smith JR
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2137-44. PubMed ID: 19567509
[TBL] [Abstract][Full Text] [Related]
29. A common genetic risk factor for colorectal and prostate cancer.
Haiman CA; Le Marchand L; Yamamato J; Stram DO; Sheng X; Kolonel LN; Wu AH; Reich D; Henderson BE
Nat Genet; 2007 Aug; 39(8):954-6. PubMed ID: 17618282
[TBL] [Abstract][Full Text] [Related]
30. Genetic predisposition to prostate cancer: an update.
Ni Raghallaigh H; Eeles R
Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571
[TBL] [Abstract][Full Text] [Related]
31. Inherited predisposition to prostate cancer.
Verhage BA; Kiemeney LA
Eur J Epidemiol; 2003; 18(11):1027-36. PubMed ID: 14620936
[TBL] [Abstract][Full Text] [Related]
32. Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer.
Brandt A; Sundquist J; Hemminki K
Ann Oncol; 2012 Jan; 23(1):251-256. PubMed ID: 21467126
[TBL] [Abstract][Full Text] [Related]
33. A rare variant, which destroys a FoxA1 site at 8q24, is associated with prostate cancer risk.
Hazelett DJ; Coetzee SG; Coetzee GA
Cell Cycle; 2013 Jan; 12(2):379-80. PubMed ID: 23255135
[No Abstract] [Full Text] [Related]
34. How I Do It: Genetic counseling and genetic testing for inherited prostate cancer.
Giri VN; Gross L; Gomella LG; Hyatt C
Can J Urol; 2016 Apr; 23(2):8247-53. PubMed ID: 27085833
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer genomics, biology, and risk assessment through genome-wide association studies.
Nakagawa H; Akamatsu S; Takata R; Takahashi A; Kubo M; Nakamura Y
Cancer Sci; 2012 Apr; 103(4):607-13. PubMed ID: 22181854
[TBL] [Abstract][Full Text] [Related]
36. [Is the prostate cancer screening behaviour of men with familial predisposition predictable?].
Paiss T; Kahn D; Küfer R; Maier C; Vogel W; Gschwend JE; Hautmann RE; Herkommer K
Urologe A; 2005 Apr; 44(4):387-92. PubMed ID: 15726312
[TBL] [Abstract][Full Text] [Related]
37. [Genetics of hereditary hematological malignancies].
Takagi M
Rinsho Ketsueki; 2015 Oct; 56(10):1969-77. PubMed ID: 26458435
[TBL] [Abstract][Full Text] [Related]
38. SNPs associated with prostate cancer risk and prognosis.
Naylor SL
Front Biosci; 2007 May; 12():4111-31. PubMed ID: 17485362
[TBL] [Abstract][Full Text] [Related]
39. Anatomic, morphologic and genetic heterogeneity of prostate cancer: implications for clinical practice.
Cheng L; MacLennan GT; Lopez-Beltran A; Montironi R
Expert Rev Anticancer Ther; 2012 Nov; 12(11):1371-4. PubMed ID: 23249102
[No Abstract] [Full Text] [Related]
40. Genome-wide association scan for variants associated with early-onset prostate cancer.
Lange EM; Johnson AM; Wang Y; Zuhlke KA; Lu Y; Ribado JV; Keele GR; Li J; Duan Q; Li G; Gao Z; Li Y; Xu J; Isaacs WB; Zheng S; Cooney KA
PLoS One; 2014; 9(4):e93436. PubMed ID: 24740154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
